Company: CNTB
Filing Date: 2025-06-10
Form Type: S-8
Source: 0001193125-25-138485
Chunk: 5

Company: Connect Biopharma Holdings Ltd
Filing Date: 2025-06-10
Form: S-8
Chunk 5
---
 individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or       
 decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of 
 prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee               
 Table” table in the effective registration statement.                                                                                                                                                                                                    |

| (iii) | to include any material information with respect to the plan of distribution not previously disclosed in the 
 registration statement or any material change to such information in the registration statement;             |

provided, however,that paragraphs (a)(1)(i) and (a)(1)(ii) of this section do not apply if registration statement is on Form S-8,and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement; and

| (2) | That, for the purpose of determining any liability under the Securities Act, each such post-effective                                                                                                                   
 amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |

| (3) | To remove from registration by means of a post-effective amendment any of the securities being registered 
 which remain unsold at the termination of the offering.                                                   |

| (b) | The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the                                                                                                                                                   
 Securities Act, each filing of the Registrant’s annual report pursuant to section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to              
 section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities 
 at that time shall be deemed to be the